Talks are underway regarding a potential $400bn mega-merger involving Pfizer, AstraZeneca, and Bristol-Myers Squibb.
3 reports, 3 independent
Updated Aug 7
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Talks are underway regarding a potential $400bn mega-merger involving Pfizer, AstraZeneca, and Bristol-Myers Squibb.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Nuveen is reportedly making a £9.9 billion approach regarding the potential mega-merger.1 source
Three major pharmaceutical companies are involved in talks of a potential $400bn mega-merger.1 source
Keep exploring
The entities involved
-
Pfizer
American multinational pharmaceutical and biotechnology corporation
-
AstraZeneca
British-Swedish pharmaceutical company
-
Bristol-Myers Squibb
American pharmaceutical company